Richard Ferrari has bought BEAT on 2 days since Feb 2025

Richard Ferrari is a seasoned medical device entrepreneur and venture capitalist who joined the Board of Directors of HeartBeam, Inc. (NASDAQ: BEAT) in 2019 and was appointed Executive Director in June 2021.( He serves as Executive Chairman of HeartBeam and holds leadership roles including Chairman and CEO at Tenon Medical, Executive Chairman at Medlumics and PQ Bypass (acquired by Endologix), Vice-Chairman at ABS Interventional, and board member at Pulmonx Corp (public) and several other medtech startups.(

Ferrari co-founded De Novo Ventures in 2000, where he has been Managing Director since, managing $650M focused on medical devices and biotechnology.( His career highlights include co-founding and leading CardioThoracic Systems (CTS) to a record-fast IPO and acquisition by Guidant for $350M, and serving as CEO of Cardiovascular Imaging Systems (CVIS), taken public and acquired by Boston Scientific for $125M.( He holds a BS from Ashland University and an MBA from the University of South Florida.( Recently, as a Director of HeartBeam, he has engaged in stock transactions, owning approximately 244,789 shares valued at over $369K as of early 2025.(

Written by Perplexity from public sources.